Options Traders Make a Beeline Toward Booming PolarityTE Stock

By Karee Venema / December 19, 2018 / www.schaeffersresearch.com / Article Link

ManDrawUp_ChartThe regenerative tissue specialist inked a deal with a major healthcare provider

Options volume is accelerated on PolarityTE Inc (NASDAQ:PTE) this afternoon, as the healthcare stock looks to snap its three day losing streak. Nearly 1,715 options are on the tape -- four times the average intraday amount -- with PTE shares up 8% at $14.52.

The upside comes following news the regenerative tissue specialist has inked a deal with the University Hospitals Cleveland Medical Center to offer its SkinTE product at the medical center's burn care and chronic non-healing wounds facilities. Plus, Cantor Fitzgerald reiterated its "overweight" rating and $65 price target -- a 346% premium to current trading levels.

Short-term options traders, meanwhile, are targeting a quick reversal for PTE stock. Amid relatively light absolute volume, the equity's December 17.50 put is likely being bought to open for a volume-weighted average price of $2.30. If this is the case, breakeven for the put buyers at the close this Friday, Dec. 21, is $15.20 (strike less premium paid).

Looking at the charts, PTE stock has struggled since its June 21 peak at $41.22, down 65%. More recently, the shares found their footing near $12.50, but subsequent rallies from here have stalled out near the formerly supportive $17.50 region, as well as the stock's descending 80-day moving average.

pte stock daily chart dec 19

Recent News

Gold and silver price ETFs see major net outflows

November 04, 2025 / canadianminingreport.com

Gold stocks decline by less than metal price

November 04, 2025 / www.canadianminingreport.com

A shift to the later stages of gold and silver bull markets

October 27, 2025 / www.canadianminingreport.com

Gold stocks plunge on metal drop

October 27, 2025 / www.canadianminingreport.com

Gold stocks still up after pullback late in the week

October 20, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok